Redose
Every published trial of tirzepatide and semaglutide reports the same headline: the most common tirzepatide side effects are gastrointestinal, and they cluster in the first weeks of treatment. In SURMOUNT 1, nausea reached 31.0% at the 15 mg dose, while diarrhea, constipation, and vomiting trailed behind. The numbers look alarming until you read the timing, which is where most of the reassurance lives.
This guide walks through what the trials actually recorded, how the side effects of tirzepatide compare with semaglutide, and how long nausea really lasts before it settles. It is a record of published data, not medical advice. Redose is a tracker for your own doses, sites, and symptoms, so nothing here tells you to start, stop, or change a medication. Follow your prescriber and use these numbers to know what the studies saw.
Tirzepatide Side Effects by the Numbers
SURMOUNT 1 randomized adults with obesity to tirzepatide 5 mg, 10 mg, or 15 mg. Across those arms, nausea ran 24.6%, 33.3%, and 31.0%. Most events were mild to moderate and showed up during the dose escalation period, not months later on a steady dose.
| Side effect | 5 mg | 15 mg |
|---|---|---|
| Nausea | 24.6% | 31.0% |
| Diarrhea | 18.7% | 23.0% |
| Vomiting | 8.3% | 12.2% |
| Constipation | 16.8% | 11.7% |
Diarrhea followed a gentle dose response, from 18.7% at 5 mg to 23.0% at 15 mg. Vomiting stayed lower, between 8.3% and 12.2%. Roughly 4.3% to 7.1% of participants stopped treatment for adverse events, against 2.6% on placebo, so most people who felt queasy kept going.
Where tirzepatide diarrhea fits in
Tirzepatide diarrhea affected about one in five people and usually passed quickly. Constipation moved the other way, easing from 16.8% at 5 mg to 11.7% at 15 mg. Both are common tirzepatide injection side effects that trackers tend to log in the first month, when the dose is still climbing.
How Semaglutide Compares on GI Effects
Semaglutide, sold as Wegovy and Ozempic, sits a little higher on the GI scale. In pooled STEP 1 to 3 data, nausea reached 43.9% versus 16.1% on placebo, and vomiting hit 24.5%. Overall, 72.9% of semaglutide participants reported at least one gastrointestinal event, against 47.1% on placebo.
| GI effect | Semaglutide | Placebo |
|---|---|---|
| Nausea | 43.9% | 16.1% |
| Vomiting | 24.5% | 6.3% |
| Diarrhea | 29.7% | 15.9% |
| Constipation | 24.2% | 11.1% |
In pooled STEP trials, 98.1% of gastrointestinal events were mild or moderate, and only 4.1% were rated severe on semaglutide 2.4 mg.
Head to head, tirzepatide tends to produce fewer of these effects than semaglutide at comparable weight loss, which is why some people compare Mounjaro side effects with Wegovy before talking to a clinician. Both drugs share the pattern: the side effects of GLP 1 drugs concentrate early and thin out with time.
How Long Nausea Really Lasts
Here is the part the raw percentages hide. GLP 1 nausea usually begins within days of the first injection or a dose increase, peaks in the first 2 to 4 weeks, and fades for most people within 1 to 3 months as the body adjusts.
GLP 1 nausea usually peaks in the first 2 to 4 weeks, then fades for most people within 1 to 3 months as the body adjusts.
The trial data backs this up. In the semaglutide analysis, the cumulative share of people hitting their first gastrointestinal event flattened after week 20, right as dose escalation ended. Individual episodes were short, which is easy to miss when you only see the headline percentages.
- Nausea episodes ran a median of 8 days
- Vomiting cleared fastest at about 2 days
- Diarrhea episodes lasted a median of 3 days
- Constipation lingered a median of 47 days
Nausea versus the slower symptoms
Nausea, vomiting, and diarrhea tend to be brief. Constipation is the outlier, running a median of 47 days, so it can feel like a long companion even when it stays mild. Knowing how long do GLP 1 side effects last helps separate a normal adjustment from something worth raising with a prescriber.
Why Every Dose Increase Restarts the Clock
Titration is the reason side effects arrive in waves. Each time the dose steps up, on the roughly 4 week schedule both labels use, the start up nausea can return briefly before settling again. Trials saw events cluster inside the escalation window, then taper once people reached a maintenance dose.
That pattern matters for anyone worried about glp 1 long term side effects. On a stable maintenance dose, most people report far fewer symptoms than they felt during the climb. Reported tirzepatide long term side effects in the trials stayed mostly gastrointestinal and mild, not new problems appearing late. You can see how the ladder tops out in our tirzepatide dose ladder guide, and how to read each step in syringe units.
On a stable maintenance dose, most trial participants reported far fewer gastrointestinal effects than they felt during titration.
Tracking Symptoms Alongside Your Doses
Percentages describe a crowd. Your own timeline is the thing worth recording. Logging each dose, the injection site, and a daily nausea score turns a vague sense of feeling off into a chart you can actually show a clinician.
A simple log answers the questions that matter. When did symptoms start relative to the last increase. Which site felt worse. Whether a meal made it better. You can use the dose calculator to confirm your syringe units first, then record what follows each injection.
- Each dose, its date, and the injection site
- A daily nausea score from 1 to 10
- Days since your last dose increase
- Foods that seemed to trigger symptoms
If you reconstitute your own vials, the reconstitution guide covers the water math that sets your concentration, so your logged units line up with the milligrams a trial reported.
How People Manage GI Effects Day to Day
Clinicians and trial participants describe the same practical moves for gastrointestinal comfort. None of this is a treatment plan, and none of it is medical advice, but it is what published guidance and patient reports repeatedly mention when nausea flares.
- Eat smaller portions and chew slowly
- Stay upright for 30 minutes after eating
- Skip greasy, spicy, and very sweet meals
- Sip water steadily, not in large gulps
- Ask a prescriber before any anti nausea aid
Meal size does most of the work. Large, greasy, or very sweet meals are the ones people flag most often, and eating slowly while staying upright afterward gives the slowed stomach time to empty. Some reach for ginger, while others ask a prescriber about anti nausea options during the worst weeks.
Common Questions About GLP 1 Side Effects
How long do GLP 1 side effects last?
For most people, GLP 1 nausea peaks in the first 2 to 4 weeks and eases within 1 to 3 months. Individual episodes on semaglutide ran a median of about 8 days. Symptoms can briefly return after each dose increase, then settle again on a stable dose.
Are there long term side effects of tirzepatide?
In SURMOUNT trials, tirzepatide long term side effects reported on maintenance were mostly the same mild gastrointestinal effects, not new conditions. Trials describe averages, not individuals, so ask your prescriber about your personal risks and history.
Does tirzepatide cause more diarrhea than nausea?
No. Across doses, nausea led at 24.6% to 33.3%, while tirzepatide diarrhea ran 18.7% to 23.0%. Vomiting was least common at 8.3% to 12.2%. All three showed up mainly during dose escalation rather than later.
Do side effects mean the medication is working?
Not necessarily. Trials found gastrointestinal events across all doses, and plenty of people lost weight with mild or no nausea. The side effects of GLP 1 drugs reflect how the gut responds to slower emptying, not a measure of results.
Track every tirzepatide dose with confidence. Redose gives you exact syringe units from the calculator, injection site rotation, gentle reminders, and a private log of every dose and side effect, so you can watch your own nausea timeline instead of guessing from trial averages. It is for tracking and record keeping only. Get the app here: iOS.